omniture
logo
Search
Accro Bioscience
Media Room

Latest News

rss

Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101

* Company to conduct a Phase II multi-regional clinical trial (MRCT) for the treatment of Ulcerat...

2024-12-13 12:57 1287

TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I

SUZHOU, China, May 24, 2023 /PRNewswire/ -- Accropeutics Bioscience announced that its oral small m...

2023-05-25 09:51 2077